[Declaration of the principles for the administration of botulinum toxin].
D001905:Botulinum Toxins / Q000008:administration & dosage / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D003357:Cosmetic Techniques / Q000941:ethics; D004311:Double-Blind Method; D004954:Esthetics; D005260:Female; D006801:Humans; D008297:Male; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D015595:Skin Aging / Q000187:drug effects
C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A